###begin article-title 0
###xml 32 37 32 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS </italic>
###xml 56 61 56 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRAF </italic>
Gene expression deregulation by KRAS G12D and G12V in a BRAF V600E context
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS </italic>
###xml 9 14 9 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRAF </italic>
###xml 292 297 292 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRAF </italic>
###xml 301 305 301 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS</italic>
###xml 305 307 305 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WT</italic>
###xml 305 307 305 307 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>WT</italic></sup>
###xml 342 352 342 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS-BRAF </italic>
###xml 402 406 402 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS</italic>
###xml 406 408 406 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WT</italic>
###xml 406 408 406 408 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>WT</italic></sup>
###xml 410 414 410 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS</italic>
###xml 414 415 414 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 417 419 417 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V </italic>
###xml 414 419 414 419 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>G</italic>12<italic>V </italic></sup>
###xml 423 427 423 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS</italic>
###xml 427 428 427 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 430 432 430 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D </italic>
###xml 427 432 427 432 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>G</italic>12<italic>D </italic></sup>
KRAS and BRAF mutations appear of relevance in the genesis and progression of several solid tumor types but the co-occurrence and interaction of these mutations have not yet been fully elucidated. Using a microsatellite stable (MSS) colorectal cancer (CRC) cell line (Colo741) having mutated BRAF and KRASWT, we also aimed to investigate the KRAS-BRAF interaction. Gene expression profiles for control KRASWT, KRASG12V and KRASG12D transfected cells were obtained after cell clone selection and RT-PCR screening. Extensive qPCR was performed to confirm microarray data.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 18 22 18 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS</italic>
###xml 22 23 22 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 25 27 25 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V </italic>
###xml 22 27 22 27 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>G</italic>12<italic>V </italic></sup>
###xml 202 206 202 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS</italic>
###xml 206 209 206 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WT </italic>
###xml 206 209 206 209 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>WT </italic></sup>
###xml 220 224 220 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS</italic>
###xml 224 225 224 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 227 229 227 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D </italic>
###xml 224 229 224 229 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>G</italic>12<italic>D </italic></sup>
We found that the KRASG12V state deregulated several genes associated to cell cycle, apoptosis and nitrogen metabolism. These findings indicated a reduced survival and proliferation with respect to the KRASWT state. The KRASG12D state was, instead, characterized by several other distinct functional changes as for example those related to chromatin organization and cell-cell adhesion without affecting apoptosis related genes.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 75 80 75 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRAF </italic>
###xml 135 139 135 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS</italic>
###xml 139 140 139 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 142 144 142 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V </italic>
###xml 139 144 139 144 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>G</italic>12<italic>V </italic></sup>
These data predict that the G12D mutation may be more likely selected in a BRAF mutated context. At the same time, the presence of the KRASG12V mutation in the cells escaping apoptosis and inducing angiogenesis via IL8 may confer a more aggressive phenotype. The present results get along with the observations that CRCs with G12V are associated with a worse prognosis with respect to the WT and G12D states and may help identifying novel CRC pathways and biomarkers of clinical relevance.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 283 286 283 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APC</italic>
###xml 343 347 343 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS</italic>
###xml 373 377 373 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TP53</italic>
###xml 501 502 501 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 642 646 642 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRAF</italic>
###xml 689 690 689 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 691 692 691 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 806 810 806 810 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MGMT</italic>
###xml 825 830 825 830 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS </italic>
###xml 889 893 889 893 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TP53</italic>
###xml 896 897 896 897 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 307 310 <span type="species:ncbi:10116">rat</span>
###xml 600 606 <span type="species:ncbi:10090">murine</span>
Normal colon epithelial cells, in their way to malignancy, may follow multiple pathways: i) the traditional adenoma-carcinoma sequence associated with chromosomal instability, in which the sequential accumulation of mutations in specific genes, including adenomatous polyposis coli (APC), v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS), and tumor protein p53 (TP53), drives the transition from healthy colonic epithelia through increasingly dysplastic adenoma to colorectal cancer (CRC) [1] ii) the serrated pathway leading to CRC associated with microsatellite instability (MSI), v-raf murine sarcoma viral oncogene homolog B1 (BRAF) mutations and extensive DNA methylation [2,3] and possibly, iii) a "fusion" pathway associated to methylation of the O-6-methylguanine DNA methyltransferase (MGMT), mutation of KRAS and inactivation of the gene coding for tumor protein p53 (TP53) [4].
###end p 9
###begin p 10
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS </italic>
###xml 121 122 121 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 243 248 243 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS </italic>
###xml 262 263 262 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 264 265 264 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 671 673 671 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 77 82 <span type="species:ncbi:9606">human</span>
KRAS is one of the most commonly activated oncogenes since 17% to 25% of all human tumors harbor mutations in this gene [5]. Although statistics may differ slightly from study to study, a good estimate is that in about 30-40% of CRC a mutated KRAS may be found [6-9]. Ras proteins are small guanine-nucleotide binding proteins (p21ras) involved in signal transduction with a GTPase activity, which is severely reduced when the protein is mutated in codons 12, 13 or 61. As p21ras activates downstream effectors in the GTP-bound state, reduction of this activity leads to unregulated signaling and lastly to enhanced and unregulated cell proliferation and transformation [10].
###end p 10
###begin p 11
###xml 61 65 61 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS</italic>
###xml 148 150 148 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 151 153 151 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 332 337 332 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TP53 </italic>
###xml 346 348 346 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 500 502 500 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 503 505 503 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 676 677 676 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 678 680 678 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 681 683 681 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 684 686 684 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
Of the multiple molecular signaling pathways initiating from KRAS, the Raf/MEK/ERK kinases and the Ras/PI3K/PTEN/Akt pathways are the best studied [11,12]. These pathways are interconnected since the mutation of genes in one pathway may influence the activity of kinases in the other pathway and both of them also interact with the TP53 pathway [12]. Because of these molecular interactions, the effects of the activation of one of these pathways may be very different in different cellular context [13,14] and may result in complex functional effects including changes in cellular proliferation, cell cycle, chromosomal instability, apoptosis, drug resistance and prognosis [8,12,15-17]. Also the role of the KRAS-BRAF interaction (being BRAF an effector of RAS in the RAF and PI3K activated pathways) is far from being understood.
###end p 11
###begin p 12
###xml 9 14 9 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRAF </italic>
###xml 159 161 159 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 162 164 162 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 182 187 182 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRAF </italic>
###xml 292 294 292 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 295 297 295 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 298 300 298 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 318 323 318 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS </italic>
###xml 327 332 327 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRAF </italic>
###xml 479 481 479 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 482 484 482 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 559 564 559 564 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS </italic>
###xml 568 573 568 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRAF </italic>
###xml 747 752 747 752 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS </italic>
###xml 795 797 795 797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 829 834 829 834 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRAF </italic>
###xml 961 966 961 966 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS </italic>
###xml 1104 1108 1104 1108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS</italic>
###xml 1115 1117 1115 1117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 1188 1193 1188 1193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRAF </italic>
###xml 1200 1202 1200 1202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 1271 1275 1271 1275 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS</italic>
###xml 1275 1276 1275 1276 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 1278 1280 1278 1280 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V </italic>
###xml 1275 1280 1275 1280 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>G</italic>12<italic>V </italic></sup>
###xml 1287 1291 1287 1291 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS</italic>
###xml 1291 1292 1291 1292 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 1294 1296 1294 1296 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D </italic>
###xml 1291 1296 1291 1296 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>G</italic>12<italic>D </italic></sup>
###xml 1334 1338 1334 1338 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS</italic>
###xml 1338 1340 1338 1340 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WT</italic>
###xml 1338 1340 1338 1340 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>WT</italic></sup>
###xml 1360 1365 1360 1365 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS </italic>
###xml 1617 1618 1617 1618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
Although BRAF mutations have been observed mainly in sporadic MSI CRC, they have also been detected in a small percentage of microsatellite stable (MSS) CRCs [18-22]. In particular, BRAF mutations were more often found in premalignant colon polyps and in early, rather than in advanced, CRC [18,23-25]. As concomitant KRAS and BRAF mutations are quite rare in premalignant colon polyps and early stages of CRC, they are considered as alternative or mutually exclusive mutations [26,27]. In a recent study, however, it was found that the number of concomitant KRAS and BRAF mutations increased along with the depth of the wall invasion of sporadic MSS CRC, suggesting that activation of both genes is likely to harbor a synergistic effect and that KRAS could give the tumor an invasive behavior [28]. Therefore, cells harboring a BRAF mutation would represent a model system with a genetic background well suited to study the specific contribution of activating KRAS mutations to CRC progression. To this end, we have used the colorectal adenocarcinoma cell line Colo741, which is wild-type relatively to KRAS, MSS [29] but harbors a mutation (V600E; single letter amino acid code) in the BRAF locus [30], and stably transfected these cells with constructs expressing the KRASG12V or the KRASG12D mutated coding sequences (cds) or the KRASWT. We selected these KRAS mutations since codon 12 is the most affected by point mutations in CRC (more than 90%) and because, among all mutation types in sporadic MSS CRC, G12D and G12V, they are the most frequently observed with a frequency of about 45% and 23% respectively [9].
###end p 12
###begin title 13
Results
###end title 13
###begin title 14
Mutated KRAS expression modifies the gene expression profile of Colo741 cells
###end title 14
###begin p 15
###xml 23 28 23 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS </italic>
###xml 210 214 210 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS</italic>
###xml 214 216 214 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WT</italic>
###xml 214 216 214 216 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>WT</italic></sup>
###xml 218 222 218 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS</italic>
###xml 222 223 222 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 225 227 225 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D </italic>
###xml 222 227 222 227 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>G</italic>12<italic>D </italic></sup>
###xml 231 235 231 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS</italic>
###xml 235 236 235 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 238 239 238 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V</italic>
###xml 235 239 235 239 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>G</italic>12<italic>V</italic></sup>
###xml 473 475 473 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 640 644 640 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS</italic>
###xml 644 645 644 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 647 649 647 649 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D </italic>
###xml 644 649 644 649 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>G</italic>12<italic>D </italic></sup>
###xml 649 660 649 660 <italic xmlns:xlink="http://www.w3.org/1999/xlink">versus KRAS</italic>
###xml 660 663 660 663 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WT </italic>
###xml 660 663 660 663 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>WT </italic></sup>
###xml 667 671 667 671 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS</italic>
###xml 671 672 671 672 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 674 675 674 675 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V</italic>
###xml 671 675 671 675 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>G</italic>12<italic>V</italic></sup>
###xml 675 686 675 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink">versus KRAS</italic>
###xml 686 689 686 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WT </italic>
###xml 686 689 686 689 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>WT </italic></sup>
###xml 837 841 837 841 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS</italic>
###xml 841 842 841 842 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 844 845 844 845 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 841 845 841 845 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>G</italic>12<italic>D</italic></sup>
###xml 845 856 845 856 <italic xmlns:xlink="http://www.w3.org/1999/xlink">versus KRAS</italic>
###xml 856 858 856 858 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WT</italic>
###xml 856 858 856 858 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>WT</italic></sup>
###xml 878 882 878 882 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS</italic>
###xml 882 883 882 883 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 885 886 885 886 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V</italic>
###xml 882 886 882 886 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>G</italic>12<italic>V</italic></sup>
###xml 886 897 886 897 <italic xmlns:xlink="http://www.w3.org/1999/xlink">versus KRAS</italic>
###xml 897 899 897 899 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WT</italic>
###xml 897 899 897 899 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>WT</italic></sup>
###xml 980 981 980 981 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 1048 1052 1048 1052 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS</italic>
###xml 1155 1156 1155 1156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 1243 1244 1243 1244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
The effects of mutated KRAS on gene expression were investigated by performing GeneChip microarray studies. Data from probed and scanned arrays (two technical replicates were analyzed for the three conditions: KRASWT, KRASG12D and KRASG12V) were normalized, filtered by removing probe sets that were regarded as not expressed and then analyzed by performing a multi-class of all 6 arrays using the SAM program. A change in gene expression was considered significant if the p value was less than 0.02 and increased gene expression occurred in, at least, one out of the three conditions. We also performed a two-class unpaired comparison for KRASG12D versus KRASWT and KRASG12Vversus KRASWT to specify expression changes. We chose a 2.0 fold change cutoff. Based on these criteria, 25 probe sets were up regulated and 61 down regulated in KRASG12Dversus KRASWT. In the comparison KRASG12Vversus KRASWT, 88 probe sets resulted up regulated and 56 down regulated (see Additional File 1). Then, another two-class unpaired comparison between the mutated KRAS-expressing Colo741 found 52 and 17 probe sets respectively up- or down-regulated (see Additional File 2). In total, irrespective of the comparison, we found 229 regulated probe sets (Figure 1) corresponded to 219 unique genes.
###end p 15
###begin p 16
###xml 91 95 91 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS</italic>
###xml 95 96 95 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 98 99 98 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 95 99 95 99 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>G</italic>12<italic>D</italic></sup>
###xml 101 105 101 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS</italic>
###xml 105 106 105 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 108 110 108 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V </italic>
###xml 105 110 105 110 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>G</italic>12<italic>V </italic></sup>
###xml 114 118 114 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS</italic>
###xml 118 121 118 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WT </italic>
###xml 118 121 118 121 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>WT </italic></sup>
Venn diagrams obtained by SAM analysis. Global comparison among the genes regulated by the KRASG12D, KRASG12V and KRASWT isoforms expressed by transfection in Colo741 cells. The number of probe sets associated to the co-regulated genes is reported in the overlapping areas.
###end p 16
###begin title 17
Analysis of gene expression profiles
###end title 17
###begin p 18
###xml 223 227 223 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS</italic>
###xml 330 334 330 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS</italic>
###xml 334 337 334 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WT </italic>
###xml 334 337 334 337 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>WT </italic></sup>
###xml 362 366 362 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS</italic>
###xml 366 367 366 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 369 371 369 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D </italic>
###xml 366 371 366 371 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>G</italic>12<italic>D </italic></sup>
###xml 375 379 375 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS</italic>
###xml 379 380 379 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 382 384 382 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V </italic>
###xml 379 384 379 384 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>G</italic>12<italic>V </italic></sup>
###xml 392 393 392 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
All the differentially 229 expressed probe sets, after creating a single sample by averaging the individual expression values from technical replicas, were then analyzed with the software tool TIGR MeV. Analysis of mutated KRAS-expressing Colo741 clones by PCA revealed a distinct partition among those expressing the recombinant KRASWT and those expressing the KRASG12D and KRASG12V (Figure 2). Points in the two-dimensional plot represented the samples. The distance between any pair of points was related to the similarity between the two observations in high-dimensional space. Samples that were near each other in the plot were similar in a large number of variables, i.e., expression level of individual genes. Conversely, samples that were far apart in the plot were different in a large number of variables.
###end p 18
###begin p 19
###xml 169 173 169 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS</italic>
###xml 173 174 173 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 176 178 176 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D </italic>
###xml 173 178 173 178 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>G</italic>12<italic>D </italic></sup>
###xml 186 190 186 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS</italic>
###xml 190 191 190 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 193 195 193 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V </italic>
###xml 190 195 190 195 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>G</italic>12<italic>V </italic></sup>
###xml 206 210 206 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS</italic>
###xml 210 213 210 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WT </italic>
###xml 210 213 210 213 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>WT </italic></sup>
###xml 605 610 605 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS </italic>
Microarray analysis performed with TIGR MeV program: principal component analysis. Microarray analysis of Colo741 cell clones transfected with constructs expressing the KRASG12D (G12D), KRASG12V (G12V) and KRASWT (WT) isoforms. Probe sets associated to dysregulation of gene expression levels among the three groups were identified using SAM (see Materials and Methods). The corresponding values from two independent microarray analysis were averaged. Principal component analysis (PCA) is shown to provide the 2D projections onto the plane spanned by the two principal components for the three different KRAS profiling data sets.
###end p 19
###begin p 20
###xml 40 45 40 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS </italic>
###xml 181 182 181 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
Differential expression among the three KRAS conditions was visualized by hierarchical clustering (HCL) which generates a tree (dendogram) to group similar objects together (Figure 3).
###end p 20
###begin p 21
Microarray analysis performed with TIGR MeV program: hierarchical clustering. Heat map visualization obtained by hierarchical clustering (HCL). Ratios for each probe relative to the mean value (calculated from the two independent microarray analysis for each condition) were used to rearrange the gene list on the basis of their expression pattern. Probes corresponding to genes with similar regulation trend were placed close to each other. The color-ratio bar indicates intensity of gene up-regulation (red), down-regulation (green) and no change (black).
###end p 21
###begin title 22
Expression patterns and biological pathways specifically identified by EASE in KRAS-expressing clones
###end title 22
###begin p 23
###xml 79 83 79 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS</italic>
###xml 101 103 101 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 232 233 232 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 238 239 238 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 367 371 367 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS</italic>
###xml 406 407 406 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 508 512 508 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS</italic>
###xml 512 513 512 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 515 516 515 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V</italic>
###xml 512 516 512 516 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>G</italic>12<italic>V</italic></sup>
###xml 542 546 542 546 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS</italic>
###xml 546 547 546 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 549 551 549 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D </italic>
###xml 546 551 546 551 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>G</italic>12<italic>D </italic></sup>
###xml 572 573 572 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 775 779 775 779 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS</italic>
###xml 820 821 820 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 885 889 885 889 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS</italic>
###xml 889 890 889 890 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 892 894 892 894 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V </italic>
###xml 889 894 889 894 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>G</italic>12<italic>V </italic></sup>
###xml 898 902 898 902 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS</italic>
###xml 902 903 902 903 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 905 906 905 906 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 902 906 902 906 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>G</italic>12<italic>D</italic></sup>
###xml 1142 1143 1142 1143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
To gain a more mechanistic understanding of the main processes affected by the KRAS, the EASE score [31] was used to identify Gene Ontology (GO) functional categories, which were significantly over-represented (see Additional Files 1 and 2). After filtering the results to avoid redundant and/or generic categories, statistically significant GO terms associated with KRAS-regulated genes were found (Table 1). This analysis identified cell cycle arrest and apoptosis genes as being the most affected ones by KRASG12V. When genes regulated by KRASG12D (see Additional File 1) were subjected to EASE analysis, genes involved in cellular component organization and biogenesis were identified. Finally, we chose to examine the 69 probe sets differently regulated between mutated KRAS-expressing Colo741 (see Additional File 2) in order to compare the specific effects of the two oncogenes KRASG12V and KRASG12D. Again, we used the EASE score to perform ontological categorization and KEGG pathway analysis. These analyses identified genes associated to immune system processes and to the biosynthesis of steroids as the most affected ones (Table 1).
###end p 23
###begin p 24
Gene Ontology analysis and KEGG pathway analysis of KRAS isoform-expressing Colo741 cell clones.
###end p 24
###begin p 25
###xml 49 54 <span type="species:ncbi:9606">Human</span>
Gene name symbols used are those approved by the Human Genome Organisation Gene Nomenclature Committee .
###end p 25
###begin p 26
###xml 235 240 235 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS </italic>
Non-redundant functional categories, number of genes contained within each category, percentages ranked by the degree of over-representation in the category as determined by EASE (P-value) and gene members found to be modulated by the KRAS isoforms are shown. Redundant categories with similar gene members were removed to yield a single representative category.
###end p 26
###begin title 27
Quantitative RT-PCR validated the Microarray data
###end title 27
###begin p 28
###xml 91 92 91 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 119 123 119 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS</italic>
###xml 412 417 412 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DDIT3</italic>
###xml 431 436 431 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SESN2</italic>
###xml 502 510 502 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PPP1R15A</italic>
###xml 591 596 591 596 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HSPB1</italic>
###xml 614 620 614 620 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SEMA6A</italic>
###xml 700 706 700 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SMCHD1</italic>
###xml 813 817 813 817 <italic xmlns:xlink="http://www.w3.org/1999/xlink">OAS1</italic>
###xml 847 850 847 850 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SYK</italic>
###xml 963 968 963 968 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FDFT1</italic>
###xml 1020 1025 1020 1025 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HMGCR</italic>
###xml 1081 1087 1081 1087 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HMGCS1</italic>
###xml 1242 1243 1242 1243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
To verify and validate the GeneChip microarray data, we performed real-time RT-PCR (Figure 4) on a subset of seventeen KRAS-modulated genes. RNA samples subjected to RT-PCR were identical to those used for the microarray analysis. In particular, we confirmed the regulated expression patterns of genes chosen on the basis of their association with cell cycle arrest processes [DNA-damage-inducible transcript 3 (DDIT3), sestrin 2 (SESN2), and protein phosphatase 1, regulatory (inhibitor) subunit 15A (PPP1R15A)], cellular component organization and biogenesis [heat shock 27 kDa protein 1 (HSPB1), semaphorin 6A (SEMA6A) and structural maintenance of chromosomes flexible hinge domain containing 1 (SMCHD1)], immune system processes [bone marrow stromal cell antigen 2 (BST2), 2',5'-oligoadenylate synthetase 1 (OAS1) and spleen tyrosine kinase (SYK)], as well as genes known to be regulated during sterol biosynthesis [farnesyl-diphosphate farnesyltransferase (FDFT1), 3-hydroxy-3-methylglutaryl-Coenzyme A reductase (HMGCR) and 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 (HMGCS1)]. All validation results, on changes in mRNA expression of these genes, were proved to be regulated coherently with the GeneChip microarray data (Figure 4). In summary, the two methodologies (real time PCR and microarray) produced highly consistent results, which provided a good level of assurance regarding the validity of the microarray data.
###end p 28
###begin p 29
###xml 0 46 0 46 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Real-Time RT-PCR validation of microarray data</bold>
###xml 154 159 154 159 <sup xmlns:xlink="http://www.w3.org/1999/xlink">G12D </sup>
###xml 171 176 171 176 <sup xmlns:xlink="http://www.w3.org/1999/xlink">G12V </sup>
###xml 191 194 191 194 <sup xmlns:xlink="http://www.w3.org/1999/xlink">WT </sup>
###xml 542 547 542 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS </italic>
###xml 857 862 857 862 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RPL19</italic>
###xml 991 996 <span type="species:ncbi:9606">Human</span>
Real-Time RT-PCR validation of microarray data. Real-Time RT-PCR analysis performed on Colo741 cell clones transfected with constructs expressing the KRASG12D (G12D), KRASG12V (G12V) and KRASWT (WT) isoforms to validate the microarray data. This was accomplished on randomly selected genes from Table 1 and showed, in arbitrary units, KRAS isoform-dependent regulation of cell cycle arrest genes (A), of cellular component organization and biogenesis genes (B), of immune system process genes (C) or sterol metabolic process genes (D). Other KRAS isoform-regulated genes associated to miscellaneous functions and randomly selected from Tables S1 and S2, are shown in (E). Real-Time RT-PCR and microarray data are respectively indicated by gray and black bars. Expression levels are relative to the expression of the housekeeping Ribosomal protein L19 gene (RPL19). Standard deviations of Real-Time RT-PCR data are indicated as vertical bars. Gene name symbols used are those approved by the Human Genome Organisation Gene Nomenclature Committee .
###end p 29
###begin title 30
Discussion
###end title 30
###begin p 31
###xml 176 181 176 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS </italic>
###xml 231 236 231 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRAF </italic>
###xml 390 395 390 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRAF </italic>
###xml 409 414 409 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS </italic>
The purpose of this study was to investigate by a genome wide transcription profiling approach the specific gene expression modulation due to the two most frequently occurring KRAS mutations in CRC (respectively, G12V and G12D) in BRAF mutated CRC-derived cells. The gene expression profiles associated to these mutations transfected in the host CRC Colo741 cells, characterized by mutated BRAF and wild type KRAS and evaluated versus the transfected WT isoform, were not overlapping and could be clear-cut discriminated. Furthermore, the Principal Component Analysis performed in this study made it evident that the highest degree of change in gene expression was to be associated to the G12V state.
###end p 31
###begin p 32
###xml 148 152 148 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS</italic>
###xml 152 153 152 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 155 156 155 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V</italic>
###xml 152 156 152 156 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>G</italic>12<italic>V</italic></sup>
###xml 388 392 388 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS</italic>
###xml 392 395 392 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WT </italic>
###xml 392 395 392 395 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>WT </italic></sup>
###xml 459 463 459 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS</italic>
###xml 463 464 463 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 466 468 466 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V </italic>
###xml 463 468 463 468 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>G</italic>12<italic>V </italic></sup>
###xml 544 549 544 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS </italic>
###xml 553 558 553 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRAF </italic>
###xml 599 603 599 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRAF</italic>
###xml 603 604 603 604 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V</italic>
###xml 607 609 607 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E </italic>
###xml 603 609 603 609 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>V</italic>600<italic>E </italic></sup>
###xml 706 708 706 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 763 768 763 768 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRAF </italic>
###xml 772 777 772 777 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS </italic>
###xml 860 862 860 862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 996 1000 996 1000 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRAF</italic>
###xml 1000 1001 1000 1001 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V</italic>
###xml 1004 1006 1004 1006 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E </italic>
###xml 1000 1006 1000 1006 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>V</italic>600<italic>E </italic></sup>
###xml 1011 1015 1011 1015 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RAS </italic>
###xml 1046 1048 1046 1048 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 1091 1096 1091 1096 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS </italic>
###xml 1100 1105 1100 1105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRAF </italic>
###xml 1499 1501 1499 1501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
Both G12D and G12V states appeared to co-regulate genes associated to biological processes which are highly correlated to cancer. The expression of KRASG12V, in particular, modulated a series of genes involved in cell cycle control, apoptosis and nitrogen metabolism so that these cells are likely to undergo cell death and/or lower proliferation with respect to the cells expressing the KRASWT isoform. Thus, it appears at first sight that the expression of KRASG12V might explain why, at least at the early stages of CRC genesis, concomitant KRAS and BRAF mutations are rarely occurring. However, BRAFV600E was shown to induce genomic instability promoting the acquisition of additional genetic defects [32] and, in the specific context of MSS CRC, concomitant BRAF and KRAS mutation occurrence was shown to increase with colon wall invasion and metastases [28]. Interestingly, Costa and coworkers reported very recently a strong link between tumor recurrence, distant metastases, survival and BRAFV600E plus RAS mutation in thyroid carcinoma [33]. It is tempting to suggest that specific KRAS and BRAF mutation interaction may have a role to modulate gene expression profiling in specific tumor types (either MSS, or MSI, or CIN) toward a more aggressive phenotype. In our view, it is not a single gene or a given genetic system that may control tumor progression. In fact, the gene expression patterns appear modulated by the genome context coupled with the effects of different gene mutations [34].
###end p 32
###begin p 33
###xml 49 53 49 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS</italic>
###xml 53 54 53 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 56 57 56 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V</italic>
###xml 53 57 53 57 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>G</italic>12<italic>V</italic></sup>
###xml 139 143 139 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HRAS</italic>
###xml 143 144 143 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 146 147 146 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V</italic>
###xml 143 147 143 147 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>G</italic>12<italic>V</italic></sup>
###xml 227 229 227 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 367 369 367 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 370 372 370 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 440 442 440 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 504 508 504 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS</italic>
###xml 508 509 508 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 511 513 511 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V </italic>
###xml 508 513 508 513 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>G</italic>12<italic>V </italic></sup>
Our data also showed that IL8 was upregulated by KRASG12V. With this in mind, we considered of high interest previous reports showing that HRASG12V-induced IL8 expression plays a critical role in tumor growth and angiogenesis [35], that the degree of its expression was associated with the CRC induction and progression including the development of liver metastases [36,37], and that IL8 was a central element in CRC-specific gene network [38]. We are therefore tempted to speculate that the presence of KRASG12V in those cells which might escape apoptosis may confer an aggressive phenotype by inducing angiogenesis via IL8 and possibly facilitate metastasis.
###end p 33
###begin p 34
###xml 56 60 56 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS</italic>
###xml 60 61 60 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 63 64 63 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 60 64 60 64 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>G</italic>12<italic>D</italic></sup>
###xml 262 268 262 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HSPB1 </italic>
###xml 272 277 272 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CRYAB</italic>
###xml 607 609 607 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 664 666 664 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
Our results also showed that the genes regulated by the KRASG12Disoform were related to the cellular component organization and biogenesis but not to apoptosis nor cell stress but instead it downregulated indeed at least two genes coding for chaperone proteins (HSPB1 and CRYAB). Since we showed that the G12V mutation generated more stressful conditions favoring cell cycle arrest and apoptosis than the G12D, it appears more likely that the BRAF mutation is associated with G12D. Interestingly, this observation appears in agreement with the data reported by Costa and collaborators in thyroid carcinoma [33] and by Oliveira and coworkers investigating the CRC [28].
###end p 34
###begin p 35
###xml 22 27 22 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS </italic>
###xml 68 73 68 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS </italic>
###xml 144 146 144 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 211 216 211 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS </italic>
###xml 374 379 374 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS </italic>
###xml 668 670 668 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
It is known that both KRAS mutations under study greatly reduce the KRAS GTPase activity, locking the protein in a constitutively active state [39] To our knowledge, however, the crystal structures of these two KRAS isoforms have not yet been determined and compared. Therefore, possible different protein-protein interactions and affinities of interactions with downstream KRAS effectors cannot be ruled out. Interestingly, these mutations were shown to affect differently the structural conformation of the highly related HRAS protein, suggesting that differences between the switch I region of G12D and G12V Ras could modify interactions with downstream effectors [39].
###end p 35
###begin p 36
###xml 47 52 47 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS </italic>
###xml 273 275 273 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 304 305 304 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 351 353 351 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 294 302 <span type="species:ncbi:9606">patients</span>
The present sets of genes modulated by the two KRAS mutations investigated were quite different (as analyzed in details in the following) and may be partly explaining the differences observed in other studies addressing their correlation with in vitro invasion properties [40], survival of CRC patients [8] and chromosomal instability and aneuploidy [41].
###end p 36
###begin p 37
###xml 49 54 49 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS </italic>
###xml 108 129 108 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC, TRPM1, SEMA6A </italic>
###xml 133 137 133 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ENO2</italic>
###xml 177 183 177 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC </italic>
###xml 227 229 227 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 251 257 251 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SPARC </italic>
###xml 298 300 298 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 303 309 303 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TRPM1 </italic>
###xml 401 403 401 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 424 431 424 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SEMA6A </italic>
###xml 521 523 521 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 600 602 600 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 616 620 616 620 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ENO2</italic>
###xml 675 677 675 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 678 680 678 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 867 871 867 871 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS</italic>
###xml 872 877 872 877 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRAF </italic>
Among the present downregulated genes in the two KRAS mutations with respect to the WT isoform, we observed SPARC, TRPM1, SEMA6A and ENO2. Reduced levels of the gene coding for SPARC was associated with therapy-refractory CRC [42] and inactivation of SPARC was related to rapid progression of CRC [43]; TRPM1 expression was found to decline with an increased degree of aggressiveness of the melanoma [44]; downregulation of SEMA6A was observed in ovarian carcinoma cell lines resistant to several chemotherapeutic drugs [45] and its extracellular domain was shown to be able to inhibit angiogenesis [46]. Concerning ENO2, literature reports indicated upregulation in cancer [47,48] rather than downregulation, as it occurred in our mutant transfected cells, but additional studies are needed to find any specific correlation of this subunit of the enolase in CRC and KRAS/BRAF mutations.
###end p 37
###begin p 38
###xml 76 81 76 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS </italic>
For the other genes that presently resulted co-regulated by the two mutated KRAS isoforms with respect to the WT isoform, we could not find in the literature a correlation with cancer. Consequently, we suggest that these genes deserve a future careful investigation as they might represent possible novel CRC markers.
###end p 38
###begin p 39
###xml 35 39 35 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS</italic>
###xml 39 40 39 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 42 43 42 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V</italic>
###xml 39 43 39 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>G</italic>12<italic>V</italic></sup>
###xml 57 104 57 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DDIT3, PPP1R15A, SESN2, APOE, DDIT3, DDIT4 ASNS</italic>
###xml 110 113 110 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CTH</italic>
###xml 305 307 305 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 308 310 308 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B58">58</xref>
###xml 322 327 322 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL24 </italic>
###xml 419 421 419 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B59">59</xref>
###xml 446 448 446 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B60">60</xref>
###xml 492 496 492 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS</italic>
###xml 496 497 496 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 499 501 499 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V </italic>
###xml 496 501 496 501 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>G</italic>12<italic>V </italic></sup>
###xml 539 544 539 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRAF </italic>
###xml 736 740 736 740 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HRAS</italic>
###xml 740 741 740 741 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 743 745 743 745 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V </italic>
###xml 740 745 740 745 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>G</italic>12<italic>V </italic></sup>
###xml 753 758 753 758 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRAF </italic>
###xml 858 860 858 860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B61">61</xref>
###xml 1046 1050 1046 1050 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HRAS</italic>
###xml 1050 1051 1050 1051 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 1053 1054 1053 1054 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V</italic>
###xml 1050 1054 1050 1054 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>G</italic>12<italic>V</italic></sup>
###xml 1117 1119 1117 1119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B62">62</xref>
###xml 1180 1184 1180 1184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS</italic>
###xml 1184 1185 1184 1185 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 1187 1189 1187 1189 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V </italic>
###xml 1184 1189 1184 1189 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>G</italic>12<italic>V </italic></sup>
###xml 1617 1619 1617 1619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B63">63</xref>
###xml 1620 1622 1620 1622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B65">65</xref>
###xml 1651 1658 1651 1658 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DHCR24 </italic>
###xml 1692 1696 1692 1696 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS</italic>
###xml 1696 1697 1696 1697 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 1699 1701 1699 1701 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V </italic>
###xml 1696 1701 1696 1701 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>G</italic>12<italic>V </italic></sup>
###xml 1861 1863 1861 1863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B66">66</xref>
###xml 1905 1914 1905 1914 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TNFRSF19 </italic>
###xml 2028 2030 2028 2030 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B67">67</xref>
###xml 2114 2116 2114 2116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B68">68</xref>
###xml 2229 2233 2229 2233 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS</italic>
###xml 2233 2234 2233 2234 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 2236 2238 2236 2238 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V </italic>
###xml 2233 2238 2233 2238 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>G</italic>12<italic>V </italic></sup>
###xml 2254 2258 2254 2258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS</italic>
###xml 2258 2259 2258 2259 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 2261 2263 2261 2263 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D </italic>
###xml 2258 2263 2258 2263 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>G</italic>12<italic>D </italic></sup>
Among the genes upregulated by the KRASG12V, we observed DDIT3, PPP1R15A, SESN2, APOE, DDIT3, DDIT4 ASNS, and CTH. All these genes are known to be induced by a variety of stressors (including unfolded protein, endoplasmic reticulum stress, DNA damage, oxidative stress, amino acid deprivation, acidosis) [49-58] and since IL24 which was also upregulated in our study, is able to activate the unfolded protein response [59] and cell cycle arrest [60], it is very likely that the expression of KRASG12V in cells already expressing a mutated BRAF unleashes a cascade of events leading to cell stress and hence possibly to apoptosis and inhibition of cell cycle progression. It is interesting to note that it was recently demonstrated that HRASG12V but not BRAF V600E engages a rapid cell-cycle arrest mediated by the endoplasmic stress response in melanocytes [61]. The upregulation of transcription of genes related to stress response resulting from our experiment is in agreement with previous reports, albeit obtained with fibroblasts expressing HRASG12V, suggesting that Ras is part of the stress sensing machinery [62]. Furthermore, the downregulation in cells transfected with KRASG12V of genes involved in sterol metabolic processes appeared to us worth to note. Interestingly, there is a large number of published studies showing that products of the mevalonate pathway are essential to the post-translational processing and function of nuclear lamins, small G proteins (including Ras), and growth factor receptors constituting a survival pathway that when inhibited induces apoptosis and inhibits angiogenesis [63-65]. The downregulation of the DHCR24 in the cells transfected with the KRASG12V isoform with respect to the WT isoform goes in the same line since this gene was reported to be associated to resistance to oxidative stress-induced apoptosis [66]. On the other hand, the upregulation of TNFRSF19 may suggest that a caspase independent cell death may take place in these cells, as already shown for 293T cells [67] and that this same gene might promote cell growth as reported for melanoma cells [68]. The significance of an upregulation of genes implicated in the immune processes in our Colo741 expressing the KRASG12V with respect to KRASG12D was less clear.
###end p 39
###begin p 40
###xml 36 40 36 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS</italic>
###xml 40 41 40 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 43 45 43 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D </italic>
###xml 40 45 40 45 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>G</italic>12<italic>D </italic></sup>
###xml 68 77 68 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HIST1H1A </italic>
###xml 78 80 78 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B69">69</xref>
###xml 86 92 86 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SMCHD1</italic>
###xml 93 95 93 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B70">70</xref>
###xml 133 140 133 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCDHB5 </italic>
###xml 144 152 144 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCDHB16 </italic>
###xml 153 155 153 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B71">71</xref>
###xml 161 167 161 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LIN7C </italic>
###xml 168 170 168 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B72">72</xref>
###xml 206 212 206 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CRYAB </italic>
###xml 213 215 213 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B73">73</xref>
###xml 221 227 221 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FHOD1 </italic>
###xml 228 230 228 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B74">74</xref>
###xml 262 267 262 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EHD2 </italic>
###xml 268 270 268 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B75">75</xref>
###xml 301 309 301 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC7A11 </italic>
###xml 310 312 310 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B76">76</xref>
###xml 339 345 339 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HSPB1 </italic>
###xml 346 348 346 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B77">77</xref>
###xml 349 351 349 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B78">78</xref>
###xml 382 390 382 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MAP3K11 </italic>
###xml 391 393 391 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B79">79</xref>
###xml 417 424 417 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SEMA6A </italic>
###xml 425 427 425 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B80">80</xref>
###xml 531 535 531 535 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS</italic>
###xml 535 536 535 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 538 540 538 540 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D </italic>
###xml 535 540 535 540 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>G</italic>12<italic>D </italic></sup>
###xml 663 671 663 671 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MAP3K11 </italic>
###xml 687 693 687 693 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LIN7C </italic>
###xml 768 770 768 770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B79">79</xref>
###xml 810 812 810 812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B72">72</xref>
###xml 879 883 879 883 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS</italic>
###xml 883 884 883 884 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 886 888 886 888 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D </italic>
###xml 883 888 883 888 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>G</italic>12<italic>D </italic></sup>
###xml 1006 1011 1006 1011 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRAF </italic>
###xml 1043 1050 1043 1050 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SEMA6A </italic>
###xml 1129 1134 1129 1134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EHD2 </italic>
###xml 1334 1341 1334 1341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCDHB5 </italic>
###xml 1345 1352 1345 1352 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PCDHB16</italic>
Among the genes associated with the KRASG12D we observed two genes, HIST1H1A [69] and SMCHD1[70], related to chromatin organization; PCDHB5 and PCDHB16 [71] and LIN7C [72] implicated in cell-cell adhesion; CRYAB [73] and FHOD1 [74] in cytoskeleton organization; EHD2 [75] in receptor internalization; SLC7A11 [76] in amino acid transport; HSPB1 [77,78] in cellular stress response; MAP3K11 [79] in invasive activity; SEMA6A [80] in axon guidance and retrograde signaling. Given the variety of processes that may be affected by the KRASG12D isoform gene expression modulation, the interpretation of our data appears quite complex. Nevertheless, since reduction of MAP3K11 and increase of LIN7C have been shown to facilitate respectively the in vitro invasive activity [79] and the oncogenic activation of PI3K [72], we suggest that the concordant modulation of these genes by the KRASG12D isoform in Colo741 cells may be functional to an higher aggressive phenotype with respect to the sole presence of the BRAF mutation. The downregulation of SEMA6A points to the same direction (see also above). Moreover, the downregulation of EHD2 may lead to increasing the growth signaling at the cell membrane by reduction of the internalization of growth receptors. Similarly, the downregulation of the proteins involved in cell-cell adhesion (PCDHB5 and PCDHB16) could possibly promote cell delamination and cell migration.
###end p 40
###begin p 41
###xml 86 90 86 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS</italic>
###xml 90 91 90 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 93 95 93 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D </italic>
###xml 90 95 90 95 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>G</italic>12<italic>D </italic></sup>
###xml 249 254 249 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS </italic>
###xml 354 360 354 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HSPB1 </italic>
###xml 364 369 364 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CRYAB</italic>
A further comment on our present expression data is that Colo741 cells expressing the KRASG12D isoform were not apoptosis-prone or stressed cells since they did not upregulate genes induced by cellular stressors with respect to cells expressing the KRAS WT isoform. Conversely, they downregulated indeed at least two genes coding for chaperone proteins (HSPB1 and CRYAB).
###end p 41
###begin p 42
In relationship with all these observations and list of genes that we have specifically considered, it is clear that specific experiments are definitely required to better clarify the role of these genes in our present CRC model.
###end p 42
###begin title 43
Conclusion
###end title 43
###begin p 44
###xml 64 69 64 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS </italic>
###xml 99 104 99 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BRAF </italic>
Our data support the hypothesis that the presently investigated KRAS mutations elicit, in the host BRAF mutated cells under study, biological consequences which may help explaining previous observations in CRC and contribute to identify novel pathways and biomarkers of potential clinical relevance.
###end p 44
###begin title 45
Methods
###end title 45
###begin title 46
Generation of stable Colo741 cell clones expressing WT, G12V and G12D KRAS mutants
###end title 46
###begin p 47
###xml 304 305 304 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S3">3</xref>
###xml 307 308 307 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S4">4</xref>
###xml 310 311 310 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S5">5</xref>
###xml 316 317 316 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S6">6</xref>
The procedures for the generation of Colo741 cell clones stably transfected with construct coding for the KRAS WT and mutant isoforms, as well as the experiments needed to assess their expression and the activation of the KRAS pathway were performed according to standard protocols (see Additional Files 3, 4, 5 and 6).
###end p 47
###begin title 48
RNA extraction and quality analysis
###end title 48
###begin p 49
###xml 35 39 35 37 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
Total RNA was isolated using RNeasy(R) MinElute columns (Qiagen). RNA concentration and purity were determined from measuring absorbance at 260 and 280 nm; 2 mug total RNA was run on a 1% denaturing gel and 100 ng were loaded on the 2100 Bioanalyzer (Agilent, Palo Alto, CA) to verify RNA integrity.
###end p 49
###begin title 50
Amplification of RNA and array hybridization
###end title 50
###begin p 51
###xml 719 724 <span type="species:ncbi:9606">Human</span>
According to the recommendations of the manufacturer, 100 ng of total RNA was used in the first-round synthesis of double-stranded cDNA. The RNA was reverse transcribed using a WT cDNA synthesis and amplification kit (Affymetrix UK Ltd., High Wycombe, UK). The resulting biotin-labeled cRNA was purified using an IVT clean-up kit (Affymetrix) and quantified using a UV spectrophotometer (A260/280; Beckman, Palo Alto, CA). An aliquot (15 mug) of cRNA was fragmented by heat and ion-mediated hydrolysis at 94degreesC for 35 minutes. Fragmented cRNA, run on the Bioanalyzer (Agilent Technologies, Santa Clara, CA) to verify the correct electropherogram, was hybridized in a hybridization oven (16 hours, 45degreesC) to a Human Gene 1.0 ST array (Affymetrix) representing whole-transcript coverage. Each one of the 28,869 genes is represented on the array by approximately 26 probes spread across the full length of the gene, providing a more complete and more accurate picture of gene expression than the 3' based expression array design. The washing and staining procedures of the arrays with phycoerythrin-conjugated streptavidin (Invitrogen) was completed in the Fluidics Station 450 (Affymetrix). The arrays were subsequently scanned using a confocal laser GeneChip Scanner 3000 7G and the GeneChip Command Console (Affymetrix).
###end p 51
###begin title 52
GeneChip microarray analysis and data normalization
###end title 52
###begin p 53
###xml 217 219 217 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B81">81</xref>
###xml 1063 1065 1063 1065 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B82">82</xref>
Affymetrix raw data files [cell intensity (CEL) files] were used as input files in expression console environment (Affymetrix). Briefly, CEL files were processed using the Robust Multi-Array Analysis (RMA) procedure [81], an algorithm that is publicly available at . The RMA method was used to convert the intensities from the multiple probes of a probe set into a single expression value with greater precision and reduced background noise (relying on the perfect match probes only and thus ignoring the mismatch probes) and then to normalize by sketch quantile normalization. Quality assessments were also performed in the expression console environment. This procedure, based on various metrics, allowed us to identify a chip as an outlier (see for details Quality assessment of exon and gene arrays . Significance Analysis of Microarrays (SAM), Principal Component Analysis (PCA) of variance and Hierarchical Clustering (HCL), after mean scaling and log2 transformation, were performed with the software tool of The Institute for Genomic Research (TIGR) MeV [82].
###end p 53
###begin p 54
###xml 102 104 102 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B83">83</xref>
Individual genes with different expression levels, among the three groups, were identified using SAM [83]. The false discovery rate expressed as q-value was used to evaluate statistical significance, and its threshold was set at 0.02 (2%). For comparison purposes, an arbitrary filter was applied excluding all genes that did not exhibit a difference in expression of at least 2-fold. Genes differentially expressed were investigated using 1) a multiclass analysis to test differences among the three groups of cells and 2) a two-class analysis within each pair groups to specify expression changes.
###end p 54
###begin p 55
We used PCA to reduce the complexity of high-dimensional data and to simplify the task of identifying patterns and sources of variability in these large data sets.
###end p 55
###begin p 56
###xml 48 50 48 50 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B84">84</xref>
The results from SAM were visualized using HCL [84].
###end p 56
###begin p 57
All the microarray information has been submitted to the National Center for Biotechnology Information Gene Expression Omnibus web site .
###end p 57
###begin title 58
Pathways identification by Expression Analysis Systemic Explore (EASE)
###end title 58
###begin p 59
Gene lists from Affymetrix results were examined using the EASE program, accessible via . EASE is a customized stand-alone software application with statistical functions for discovering biological themes within gene lists. This software assigns genes of interest into functional categories based on the Gene Ontology database (GO, ) and uses the Fisher's exact test statistics to determine the probability of observing the number of genes within a list of interest versus the number of genes in each category on the array. A more detailed analysis of the genes' association with physiological pathways was performed using the Kyoto Encyclopedia of Genes and Genomes (KEGG, ). Each identified process was confirmed through PubMed/Medline.
###end p 59
###begin title 60
RT-PCR analysis
###end title 60
###begin p 61
Starting from about 1 mug of total RNA, cDNA was synthesized by using an Oligo(dT)20, random hexamers mix and a Superscript III first-strand synthesis system supermix for RT-PCR (Invitrogen). cDNAs were diluted 5 - 20 times, then subjected to PCR analysis.
###end p 61
###begin p 62
###xml 253 258 253 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RPL19</italic>
Relative quantification was performed by real-time quantitative RT-PCR (qPCR) sybrgreen using the ABI Prism 7700 Sequence Detector (Applied Biosystems, Foster City, CA) following manufacturer's instructions. The housekeeping gene ribosomal protein L19 (RPL19) was used as the endogenous control for normalization because, in the microarray data, it showed in all conditions the steadiest expression when normally used housekeeping genes were compared.
###end p 62
###begin p 63
###xml 238 239 238 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S7">7</xref>
To avoid possible signal production from potential contaminating genomic DNA, specific primers for each gene were designed across a common exon-exon splice junction by the Primer Express software (Applied Biosystems) (see Additional File 7). Dissociation curve analysis defined the specificity of the products by the presence of a single dissociation peak on the thermal melting curve.
###end p 63
###begin title 64
Competing interests
###end title 64
###begin p 65
The authors declare that they have no competing interests.
###end p 65
###begin title 66
Authors' contributions
###end title 66
###begin p 67
MMo designed research, performed research, analyzed data, wrote paper; EB, MMa, AD FR and CTS performed research; WG designed research, analyzed data, wrote paper; PC designed research, performed research, analyzed data, wrote paper.
###end p 67
###begin title 68
Supplementary Material
###end title 68
###begin title 69
Additional file 1
###end title 69
###begin p 70
###xml 52 57 52 57 <sup xmlns:xlink="http://www.w3.org/1999/xlink">G12V </sup>
###xml 65 70 65 70 <sup xmlns:xlink="http://www.w3.org/1999/xlink">G12D </sup>
###xml 77 83 77 83 <sup xmlns:xlink="http://www.w3.org/1999/xlink">G12WT </sup>
###xml 202 206 202 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS</italic>
###xml 206 207 206 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 209 211 209 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V </italic>
###xml 206 211 206 211 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>G</italic>12<italic>V </italic></sup>
###xml 214 218 214 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS</italic>
###xml 218 219 218 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 221 223 221 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D </italic>
###xml 218 223 218 223 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>G</italic>12<italic>D </italic></sup>
###xml 467 471 467 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS</italic>
###xml 471 473 471 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WT</italic>
###xml 471 473 471 473 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>WT</italic></sup>
Table S1. Probe sets significantly regulated by KRASG12V and KRASG12D Vs KRASG12WT in Colo741 cell clones. Probe sets ID, with relative gene symbols or Ensembl Transcript ID, significantly regulated by KRASG12V or KRASG12D in Colo741 cell clones, as determined by using SAM software with multi-class analysis. Q-values were calculated using the two-class, unpaired, option with the additional requirement of at least a 2-fold change in gene expression, relatively to KRASWT-expressing clones.
###end p 70
###begin p 71
Click here for file
###end p 71
###begin title 72
Additional file 2
###end title 72
###begin p 73
###xml 55 60 55 60 <sup xmlns:xlink="http://www.w3.org/1999/xlink">G12V </sup>
###xml 67 72 67 72 <sup xmlns:xlink="http://www.w3.org/1999/xlink">G12D </sup>
Table S2. Probe sets ID significantly regulated in KRASG12V Vs KRASG12D transfected Colo741 cell clones. Probe sets ID, with relative gene symbols or Ensembl Transcript ID, significantly regulated in the comparison between the clones bearing the KRAS mutations (G12V and G12D). Q-values were calculated as in table S1.
###end p 73
###begin p 74
Click here for file
###end p 74
###begin title 75
Additional file 3
###end title 75
###begin p 76
Supplemental Methods. Methods for; generation of KRAS expression constructs, cells and cell culture, immunolocalization, establishment and selection of stable cell clones and Western blot analysis.
###end p 76
###begin p 77
Click here for file
###end p 77
###begin title 78
Additional file 4
###end title 78
###begin p 79
###xml 69 78 69 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro </italic>
###xml 134 138 134 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS</italic>
###xml 138 141 138 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WT </italic>
###xml 138 141 138 141 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>WT </italic></sup>
###xml 151 155 151 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS</italic>
###xml 155 156 155 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 158 159 158 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V</italic>
###xml 155 159 155 159 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>G</italic>12<italic>V</italic></sup>
###xml 172 176 172 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS</italic>
###xml 176 177 176 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 179 181 179 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D </italic>
###xml 176 181 176 181 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>G</italic>12<italic>D </italic></sup>
###xml 216 220 216 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS</italic>
###xml 220 223 220 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WT </italic>
###xml 220 223 220 223 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>WT </italic></sup>
###xml 439 443 439 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS</italic>
###xml 443 444 443 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 446 448 446 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V </italic>
###xml 443 448 443 448 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>G</italic>12<italic>V </italic></sup>
###xml 1048 1052 1048 1052 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS</italic>
###xml 1052 1053 1052 1053 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 1055 1057 1055 1057 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V </italic>
###xml 1052 1057 1052 1057 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>G</italic>12<italic>V </italic></sup>
Figure S1. Expression and localization of recombinant KRAS proteins. In vitro transcription/translation of the empty vector (lane 1), KRASWT (lane 2), KRASG12V(lane 3) and KRASG12D (lane 4), recombinant chimera RED2:KRASWT (lane 5) and luciferase (control) expressing plasmids (lane 6) (A). Arrow heads point to the position of molecular mass standards whose sizes are expressed in kDa (A). Cells after 48 hours from transfection with CFP-KRASG12V construct (B-G). Immunolocalization by an anti-pan-Ras antibody (F, G) and an Alexa514-conjugated secondary antibody giving a green signal (C, D, F, G,), direct visualization of the cyan signal pseudocolored in red (B, D, E, G) and direct visualization of the signal displayed by the nuclear dye 7-Amino Actinomycin D pseudocolored in blue (D, G). The merged fluorescence signals are shown in (D, G). Magnification of the area in the white rectangles are shown in the lower left insets of (E-G). Arrow heads point to some of the cell membrane regions displaying colocalization of the pan-RAS and CFP-KRASG12V signals. Gamma adjustment was applied to each panel to adapt color rendering in the CMYK process. Scale bar = 50 mm.
###end p 79
###begin p 80
Click here for file
###end p 80
###begin title 81
Additional file 5
###end title 81
###begin p 82
###xml 123 126 123 126 <sup xmlns:xlink="http://www.w3.org/1999/xlink">WT </sup>
###xml 136 141 136 141 <sup xmlns:xlink="http://www.w3.org/1999/xlink">G12D </sup>
###xml 156 161 156 161 <sup xmlns:xlink="http://www.w3.org/1999/xlink">G12V </sup>
###xml 562 567 562 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS </italic>
###xml 751 757 751 757 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAPDH </italic>
Figure S2. Screening by semiquantitative RT-PCR analysis of Colo741 cell clones transfected with constructs expressing KRASWT (WT), KRASG12D (G12D) and KRASG12V (G12V) mRNA isoforms. For each construct both cell clones expressing the transgene (1D8-3C7-4D3) and cell clones not expressing the transgene (2G7-1H2-1B3) are shown. The latter were discarded from further experiments. For all the assayed samples, a reverse transcription PCR assays, performed omitting the reverse transcriptase, was also carried out to exclude from further analysis clones yelding a KRAS amplicon resulting from a plasmid integrated in the genomic DNA (false positive samples). In this example no amplicons were detected in minus reverse transcriptase assays. Primers for GAPDH were used to normalize the results.
###end p 82
###begin p 83
Click here for file
###end p 83
###begin title 84
Additional file 6
###end title 84
###begin p 85
###xml 117 121 117 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS</italic>
###xml 121 124 121 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WT </italic>
###xml 121 124 121 124 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>WT </italic></sup>
###xml 134 138 134 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS</italic>
###xml 138 139 138 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 141 143 141 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V </italic>
###xml 138 143 138 143 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>G</italic>12<italic>V </italic></sup>
###xml 153 157 153 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS</italic>
###xml 157 158 157 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 160 162 160 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D </italic>
###xml 157 162 157 162 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>G</italic>12<italic>D </italic></sup>
###xml 185 190 <span type="species:ncbi:9606">human</span>
Figure S3. Western blotting analysis of selected Colo741 KRAS-expressing clones. Vector-transfected clones (lane 1), KRASWT (lane 2), KRASG12V (lane 3), KRASG12D (lane 4) and senescent human bone marrow stromal cells (lane 5) were subjected to immunoblotting to establish the global Ras expression (pan-Ras) (A) and the phosphorylation status of AKT (B) and ERK1/2 (C). Arrow points to the pAKT protein.
###end p 85
###begin p 86
Click here for file
###end p 86
###begin title 87
Additional file 7
###end title 87
###begin p 88
Table S3. Sequences accession numbers and primers.
###end p 88
###begin p 89
Click here for file
###end p 89
###begin title 90
Acknowledgements
###end title 90
###begin p 91
###xml 11 15 11 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRAS</italic>
###xml 15 16 15 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 18 20 18 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V </italic>
###xml 15 20 15 20 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>G</italic>12<italic>V </italic></sup>
The pcDNA3-KRASG12V was a kind gift from Dr. Natalia Ignatenko, Department of Cell Biology and Anatomy, University of Arizona. This work was supported by CIPE 2007-Regione Liguria (Stem Cells), "Ministero della Salute 2004" and "Compagnia di San Paolo" (project 2007.0266).
###end p 91
###begin article-title 92
Genetic alterations during colorectal-tumor development
###end article-title 92
###begin article-title 93
BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum
###end article-title 93
###begin article-title 94
Promoter hypermethylation frequency and BRAF mutations distinguish hereditary non-polyposis colon cancer from sporadic MSI-H colon cancer
###end article-title 94
###begin article-title 95
Advanced colorectal polyps with the molecular and morphological features of serrated polyps and adenomas: concept of a 'fusion' pathway to colorectal cancer
###end article-title 95
###begin article-title 96
The KRAS oncogene: past, present, and future
###end article-title 96
###begin article-title 97
Clinical and pathological associations with allelic loss in colorectal carcinoma [corrected]
###end article-title 97
###begin article-title 98
Prognostic significance of K-ras mutations in colorectal carcinoma
###end article-title 98
###begin article-title 99
###xml 25 33 <span type="species:ncbi:9606">patients</span>
Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study
###end article-title 99
###begin article-title 100
Distinct patterns of KRAS mutations in colorectal carcinomas according to germline mismatch repair defects and hMLH1 methylation status
###end article-title 100
###begin article-title 101
Intrinsic GTPase activity distinguishes normal and oncogenic ras p21 molecules
###end article-title 101
###begin article-title 102
Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy
###end article-title 102
###begin article-title 103
Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance
###end article-title 103
###begin article-title 104
Tumor induction by an endogenous K-ras oncogene is highly dependent on cellular context
###end article-title 104
###begin article-title 105
Oncogenic KRAS provides a uniquely powerful and variable oncogenic contribution among RAS family members in the colonic epithelium
###end article-title 105
###begin article-title 106
Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects
###end article-title 106
###begin article-title 107
Mutant KRAS, chromosomal instability and prognosis in colorectal cancer
###end article-title 107
###begin article-title 108
KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer
###end article-title 108
###begin article-title 109
Similarity of the phenotypic patterns associated with BRAF and KRAS mutations in colorectal neoplasia
###end article-title 109
###begin article-title 110
BRAF mutations characterize colon but not gastric cancer with mismatch repair deficiency
###end article-title 110
###begin article-title 111
BRAF mutations in colon cancer are not likely attributable to defective DNA mismatch repair
###end article-title 111
###begin article-title 112
###xml 55 60 <span type="species:ncbi:9606">human</span>
Mutation analysis of the BRAF, ARAF and RAF-1 genes in human colorectal adenocarcinomas
###end article-title 112
###begin article-title 113
Concomitant RASSF1A hypermethylation and KRAS/BRAF mutations occur preferentially in MSI sporadic colorectal cancer
###end article-title 113
###begin article-title 114
Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status
###end article-title 114
###begin article-title 115
BRAF and KRAS mutations in colorectal hyperplastic polyps and serrated adenomas
###end article-title 115
###begin article-title 116
###xml 60 65 <span type="species:ncbi:9606">human</span>
BRAF mutation associated with dysregulation of apoptosis in human colorectal neoplasms
###end article-title 116
###begin article-title 117
Mutation analysis of p53, K-ras, and BRAF genes in colorectal cancer progression
###end article-title 117
###begin article-title 118
RAS signaling in colorectal carcinomas through alteration of RAS, RAF, NF1, and/or RASSF1A
###end article-title 118
###begin article-title 119
KRAS and BRAF oncogenic mutations in MSS colorectal carcinoma progression
###end article-title 119
###begin article-title 120
CpG island methylation is a common finding in colorectal cancer cell lines
###end article-title 120
###begin article-title 121
###xml 30 35 <span type="species:ncbi:9606">human</span>
Mutations of the BRAF gene in human cancer
###end article-title 121
###begin article-title 122
Identifying biological themes within lists of genes with EASE
###end article-title 122
###begin article-title 123
Conditional BRAFV600E expression induces DNA synthesis, apoptosis, dedifferentiation, and chromosomal instability in thyroid PCCL3 cells
###end article-title 123
###begin article-title 124
BRAF mutation associated with other genetic events identifies a subset of aggressive papillary thyroid carcinoma
###end article-title 124
###begin article-title 125
Patterns of genome dynamics and cancer evolution
###end article-title 125
###begin article-title 126
Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis
###end article-title 126
###begin article-title 127
Correlation of IL-8 with induction, progression and metastatic potential of colorectal cancer
###end article-title 127
###begin article-title 128
Influence of interleukin-8 and interleukin-10 on sporadic colon cancer development and progression
###end article-title 128
###begin article-title 129
Constructing disease-specific gene networks using pair-wise relevance metric: application to colon cancer identifies interleukin 8, desmin and enolase 1 as the central elements
###end article-title 129
###begin article-title 130
Structural differences between valine-12 and aspartate-12 Ras proteins may modify carcinoma aggression
###end article-title 130
###begin article-title 131
Differences in in vitro invasive capacity induced by differences in Ki-Ras protein mutations
###end article-title 131
###begin article-title 132
###xml 29 34 <span type="species:ncbi:9606">human</span>
Specific K-ras2 mutations in human sporadic colorectal adenomas are associated with DNA near-diploid aneuploidy and inhibition of proliferation
###end article-title 132
###begin article-title 133
Genome-wide expression analysis of therapy-resistant tumors reveals SPARC as a novel target for cancer therapy
###end article-title 133
###begin article-title 134
Frequent inactivation of SPARC by promoter hypermethylation in colon cancers
###end article-title 134
###begin article-title 135
Melastatin expression and prognosis in cutaneous malignant melanoma
###end article-title 135
###begin article-title 136
From plasma membrane to cytoskeleton: a novel function for semaphorin 6A
###end article-title 136
###begin article-title 137
Recombinant semaphorin 6A-1 ectodomain inhibits in vivo growth factor and tumor cell line-induced angiogenesis
###end article-title 137
###begin article-title 138
###xml 61 68 <span type="species:ncbi:9606">patient</span>
Expression and interconversion of neuron-specific enolase in patient sera and extracts from small-cell lung cancer cells
###end article-title 138
###begin article-title 139
Value of tumor markers in diagnosing and monitoring colorectal cancer and strategies for further improvement: analysis of 130 cases
###end article-title 139
###begin article-title 140
Endoplasmic reticulum stress induced by oxidative stress in retinal pigment epithelial cells
###end article-title 140
###begin article-title 141
Growth arrest and DNA damage-inducible protein GADD34 targets protein phosphatase 1 alpha to the endoplasmic reticulum and promotes dephosphorylation of the alpha subunit of eukaryotic translation initiation factor 2
###end article-title 141
###begin article-title 142
###xml 64 69 <span type="species:ncbi:9606">human</span>
Induction of GADD gene expression by phenethylisothiocyanate in human colon adenocarcinoma cells
###end article-title 142
###begin article-title 143
Identification of a novel stress-responsive gene Hi95 involved in regulation of cell viability
###end article-title 143
###begin article-title 144
Oxidative stress regulates adipocyte apolipoprotein E and suppresses its expression in obesity
###end article-title 144
###begin article-title 145
Elevated gadd153/chop expression and enhanced c-Jun N-terminal protein kinase activation sensitizes aged cells to ER stress
###end article-title 145
###begin article-title 146
The stress-inducted proteins RTP801 and RTP801L are negative regulators of the mammalian target of rapamycin pathway
###end article-title 146
###begin article-title 147
###xml 204 209 <span type="species:ncbi:9606">human</span>
Amino acid deprivation and endoplasmic reticulum stress induce expression of multiple activating transcription factor-3 mRNA species that, when overexpressed in HepG2 cells, modulate transcription by the human asparagine synthetase promoter
###end article-title 147
###begin article-title 148
HepG2/C3A cells respond to cysteine deprivation by induction of the amino acid deprivation/integrated stress response pathway
###end article-title 148
###begin article-title 149
Mechanism of increased renal gene expression during metabolic acidosis
###end article-title 149
###begin article-title 150
The tumor suppressor activity of MDA-7/IL-24 is mediated by intracellular protein expression in NSCLC cells
###end article-title 150
###begin article-title 151
Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties
###end article-title 151
###begin article-title 152
Anti-oncogenic role of the endoplasmic reticulum differentially activated by mutations in the MAPK pathway
###end article-title 152
###begin article-title 153
Ha-ras(val12) induces HSP70b transcription via the HSE/HSF1 system, but HSP70b expression is suppressed in Ha-ras(val12)-transformed cells
###end article-title 153
###begin article-title 154
HMG-CoA reductase inhibitor simvastatin overcomes bortezomib-induced apoptosis resistance by disrupting a geranylgeranyl pyrophosphate-dependent survival pathway
###end article-title 154
###begin article-title 155
Studies of the isoprenoid-mediated inhibition of mevalonate synthesis applied to cancer chemotherapy and chemoprevention
###end article-title 155
###begin article-title 156
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 43 48 <span type="species:ncbi:9606">human</span>
Human umbilical vein endothelial cells and human dermal microvascular endothelial cells offer new insights into the relationship between lipid metabolism and angiogenesis
###end article-title 156
###begin article-title 157
DHCR24 gene expression is upregulated in melanoma metastases and associated to resistance to oxidative stress-induced apoptosis
###end article-title 157
###begin article-title 158
An alternative form of paraptosis-like cell death, triggered by TAJ/TROY and enhanced by PDCD5 overexpression
###end article-title 158
###begin article-title 159
Tumor necrosis factor receptor superfamily member TROY is a novel melanoma biomarker and potential therapeutic target
###end article-title 159
###begin article-title 160
###xml 54 59 <span type="species:ncbi:9606">human</span>
Rapid exchange of histone H1.1 on chromatin in living human cells
###end article-title 160
###begin article-title 161
SmcHD1, containing a structural-maintenance-of-chromosomes hinge domain, has a critical role in X inactivation
###end article-title 161
###begin article-title 162
###xml 37 42 <span type="species:ncbi:10090">mouse</span>
###xml 47 52 <span type="species:ncbi:9606">human</span>
Comparative DNA sequence analysis of mouse and human protocadherin gene clusters
###end article-title 162
###begin article-title 163
###xml 57 67 <span type="species:ncbi:7227">Drosophila</span>
Oncogenic function for the Dlg1 mammalian homolog of the Drosophila discs-large tumor suppressor
###end article-title 163
###begin article-title 164
Association of the chaperone alphaB-crystallin with titin in heart muscle
###end article-title 164
###begin article-title 165
The formin/diaphanous-related protein, FHOS, interacts with Rac1 and activates transcription from the serum response element
###end article-title 165
###begin article-title 166
C-terminal EH-domain-containing proteins: consensus for a role in endocytic trafficking, EH?
###end article-title 166
###begin article-title 167
The xc-cystine/glutamate antiporter: a mediator of pancreatic cancer growth with a role in drug resistance
###end article-title 167
###begin article-title 168
Small stress proteins: modulation of intracellular redox state and protection against oxidative stress
###end article-title 168
###begin article-title 169
Heat shock protein 27 prevents cellular polyglutamine toxicity and suppresses the increase of reactive oxygen species caused by huntingtin
###end article-title 169
###begin article-title 170
A precisely regulated gene expression cassette potently modulates metastasis and survival in multiple solid cancers
###end article-title 170
###begin article-title 171
###xml 16 21 <span type="species:ncbi:9606">human</span>
###xml 26 32 <span type="species:ncbi:10090">murine</span>
The orthologous human and murine semaphorin 6A-1 proteins (SEMA6A-1/Sema6A-1) bind to the enabled/vasodilator-stimulated phosphoprotein-like protein (EVL) via a novel carboxyl-terminal zyxin-like domain
###end article-title 171
###begin article-title 172
Exploration, normalization, and summaries of high density oligonucleotide array probe level data
###end article-title 172
###begin article-title 173
TM4: a free, open-source system for microarray data management and analysis
###end article-title 173
###begin article-title 174
Significance analysis of microarrays applied to the ionizing radiation response
###end article-title 174
###begin article-title 175
Cluster analysis and display of genome-wide expression patterns
###end article-title 175

